A Pharmacokinetic Study of Tedizolid Phosphate in Pediatric Participants With Gram-Positive Infections (MK-1986-014)
Clinical trial NCT03217565 · COMPLETED
Trial details
- NCT number
- NCT03217565
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-06
- Primary completion
- 2023-03-18
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.